News
Mutation in DOCK11 gene explains rare disorder in immune system regulation
Researchers from the Institut de Recerca Sant Joan de Déu - SJD Barcelona Children's Hospital participate in an international study, published in the prestigious scientific journal New England Journal of Medicine, which describes for the first time a new disease of the immune system caused by a mutation of the DOCK11 gene.
An aggressive childhood cancer case opens new avenues for advanced cell therapies
A positive response to therapy in a paediatric patient with a renal rhabdoid tumour has enabled researchers to identify immune cells with anti-tumour activity in this rare cancer.
A study led by Sant Joan de Déu shows promising results for a new treatment for childhood cerebral adrenoleukodystrophy
An international study led by Sant Joan de Déu explores the first oral therapy to slow childhood cerebral adrenoleukodystrophy, a devastating rare disease.
New alliance between the Institut de Recerca Sant Joan de Déu and the BSC to advance pediatric research
Both entities will establish joint research groups with the aim of consolidating Barcelona as a European benchmark in child biomedical research.
Agenda
Defensa tesi doctoral: Berta Estévez Arias
"'Precision medicine for rare neuromuscular diseases: clinical, genetic and pathophysiological studies"
Defensa tesi doctoral: Laura Carrera García
"Atrofia muscular espinal Tipo 2: historia natural e impacto de las nuevas terapias"
Interviews
Manel González-Piñero
Headof Innovation at CREB UPC and XarTEC SALUT
"Our main objectives are to develop a technologies map of the members of XarTEC SALUT and to find the most effective ways to support them."
Read more More Interviews
